Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

First report of kappa-opioid agonist efficacy in humans

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

New treatment options for ALS

July 18, 1997

BDNF shows potential for stroke therapy in rat model

July 18, 1997

MS&D continues to pursue antimigraine agents

July 18, 1997

Promising preliminary results reported for Interneuron's ischemic stroke treatment

July 17, 1997

FDA approves first medical device for epilepsy

July 17, 1997

Acetylcholine receptor modulators reported by SIBIA Neurosciences

July 17, 1997

Biomedica Foscama discloses adenosine antagonists for depression

July 17, 1997

Merck Sharp & Dohme reveals new tachykinin antagonists

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...